Example: Heart Attack

Search clinical trials for: Diphenhydramine

Total 137 results

NCT03968939

Recruiting

Total Joint Arthroplasty and Sleep

Conditions: Primary Total Hip Arthroplasty, Primary Total Knee Arthroplasty
NCT04629248

Recruiting

A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy

Conditions: Primary Membranous Nephropathy
NCT02037126

Recruiting

Psilocybin-facilitated Treatment for Cocaine Use

Conditions: Cocaine-Related Disorders
NCT04862585

Not yet recruiting

Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel

Conditions: Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Breast Carcinoma, Prognostic Stage 0 Breast Cancer AJCC v8, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8
NCT04862221

Not yet recruiting

TReatment for ImmUne Mediated PathopHysiology

Conditions: Acute Liver Failure, Fulminant Hepatic Failure, Hepatic Encephalopathy, Acute Liver Injury, Immune Dysregulation
NCT04660799

Recruiting

A Study on Pharmacokinetics (PK), Efficacy and Safety of Subcutaneous (SC) Versus Intravenous (IV) Rituximab, in Combination With CHOP (Cyclophosphamide, Doxorubicin, Vincristine, Prednisone) in Previously Untreated Participants With CD20 Positive Diffuse Large B-Cell Lymphoma (DLBCL)

Conditions: Lymphoma, Large B-Cell, Diffuse
NCT02240407

Recruiting

Re-administration of Intramuscular AAV9 in Patients With Late-Onset Pompe Disease

Conditions: Pompe Disease
NCT04165096

Recruiting

KEYMAKER-U01 Substudy 3: Efficacy and Safety Study of Pembrolizumab (MK-3475) When Used With Investigational Agents in Participants With Advanced Non-small Cell Lung Cancer (NSCLC), Previously Treated With Anti-programmed Cell Death Receptor Ligand 1 (PD-L1) Therapy (MK-3475-01C/KEYMAKER-U01C)

Conditions: Carcinoma, Non-Small-Cell Lung
NCT04846348

Not yet recruiting

Topical Composition Therapy for the Treatment of Cutaneous Mastocytosis

Conditions: Cutaneous Mastocytoses
NCT04221477

Recruiting

A Study To Evaluate The Efficacy And Safety Of Obinutuzumab In Patients With ISN/RPS 2003 Class III Or IV Lupus Nephritis

Conditions: Lupus Nephritis
NCT04294459

Recruiting

Safety, Pharmacokinetics, and Preliminary Efficacy of Isatuximab in Patients Awaiting Kidney Transplantation

Conditions: Immune System Disorder
NCT01086540

Completed

Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)

Conditions: Systemic Sclerosis-Associated PAH
NCT04661033

Not yet recruiting

Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia

Conditions: Warm Autoimmune Hemolytic Anemia
NCT03913559

Recruiting

Inotuzumab Ozogamicin for Children With MRD Positive CD22+ Lymphoblastic Leukemia

Conditions: Acute Lymphoblastic Leukemia
NCT04659603

Recruiting

SAR408701 in Patients With CEACAM5-positive Advanced Solid Tumors

Conditions: Breast Cancer Metastatic, Pancreatic Carcinoma Metastatic
NCT04093271

Completed

Investigating the Efficacy of Rest-ZZZ Formula in Healthy Participants With Difficulty Falling Asleep or Staying a Sleep

Conditions: Sleep, Healthy
NCT01998971

Active, not recruiting

A Study of JNJ-54767414 (HuMax CD38) (Anti-CD38 Monoclonal Antibody) in Combination With Backbone Treatments for the Treatment of Patients With Multiple Myeloma

Conditions: Multiple Myeloma
NCT04401020

Recruiting

First-in-human Single Agent Study of SAR442257 in RRMM and RR-NHL

Conditions: Neoplasm Malignant
NCT04189588

Completed

Phase 2 Study IV QUZYTTIR™ (Cetirizine Hydrochloride Injection) vs V Diphenhydramine

Conditions: Oncology Patients Receiving Chemotherapy
NCT01888497

Completed

Next-Day Residual Effects of Gabapentin, Diphenhydramine and Triazolam on Simulated Driving Performance in Normal Volunteers

Conditions: Healthy
NCT04224558

Recruiting

Stem Cell Transplantation in Crohn's Disease

Conditions: Crohn Disease
NCT04456439

Available

Intermediate-size Expanded Access Program (EAP), Mesenchymal Stromal Cells (MSC) for Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)

Conditions: Multisystem Inflammatory Syndrome in Children (MIS-C) Associated With Coronavirus Disease (COVID-19)
NCT02474199

Completed

Donor Alloantigen Reactive Tregs (darTregs) for Calcineurin Inhibitor (CNI) Reduction

Conditions: Liver Transplant Recipient, Living Donor (of the Respective Liver Transplant Recipient)
NCT04700007

Recruiting

Evaluation of Peripheral Itch Mechanisms Following Injection of Morphine (Second Sub-Project)

Conditions: Itch
NCT04741139

Not yet recruiting

Post IVIG Medication in Children With Immune Thrombocytopenia

Conditions: Immune Thrombocytopenia